(-0.11%) 5 463.53 points
(-0.07%) 39 086 points
(0.12%) 17 739 points
(-0.64%) $80.31
(-4.32%) $2.64
(-0.79%) $2 312.40
(0.13%) $28.91
(2.33%) $1 009.40
(0.29%) $0.936
(0.70%) $10.68
(0.47%) $0.792
(-0.16%) $87.35
Live Chart Being Loaded With Signals
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD)...
Stats | |
---|---|
Today's Volume | 60 423 |
Average Volume | 22 358 |
Market Cap | 25.49M |
EPS | $-0.580 ( Q3 | 2023-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0960 (7.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-10 | Bitterman Kevin | Sell | 20 000 | Common Stock |
2024-01-10 | Atlas Venture Fund X, L.p. | Sell | 30 000 | Common Stock |
2024-01-10 | Atlas Venture Fund X, L.p. | Sell | 20 000 | Common Stock |
2023-12-29 | Quisel John D | Sell | 2 700 | Stock Option (Right to Buy) |
2023-12-29 | Quisel John D | Buy | 2 700 | Common Stock |
INSIDER POWER |
---|
-92.97 |
Last 100 transactions |
Buy: 61 440 | Sell: 1 683 907 |
Volume Correlation
Gemini Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Gemini Therapeutics, Inc. Correlation - Currency/Commodity
Gemini Therapeutics, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $0 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.667 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.0538 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators